Hopp til innhold
NHI.no
Annonse

Diagnostikk av helvetesild

Innhold i artikkelen

Sykehistorien og de typiske symptomene gjør at diagnosen i typiske tilfeller er enkel å stille. Utslettet er tydelig avgrenset på huden, og de væskefylte blemmene er oftest lett å gjenkjenne. I dagene før utslettet viser seg, kan tilstanden forveksles med andre tilstander som gir smerter.

Annonse

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Herpes zoster . Referanselisten for dette dokumentet vises nedenfor

  1. Asada H. Recent topics in the management of herpes zoster. J Dermatol. 2023 Mar;50(3):305-310. Epub 2022 Dec 20. PMID: 36539935 PubMed
  2. van Oorschot D, Vroling H, Bunge E, Diaz-Decaro J, Curran D, Yawn B. A systematic literature review of herpes zoster incidence worldwide. Hum Vaccin Immunother. 2021;17(6):1714-1732. PMID: 33651654 PubMed
  3. FHI - Smittevernhåndboka. Sist oppdatert 04.03.2025. Sist lest: 19.06.2025. www.fhi.no
  4. Kofoed K, Rønholt F, Gerstoft J, Sand C. Herpes zoster: klinik, diagnostik og behandling. Ugeskr Læger 2011; 173: 114. Ugeskrift for Læger
  5. Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Langan SM. Quantification of risk factors for herpes zoster: population based case-control study. BMJ. 2014;348:g2911. Published 2014 May 13. PMID: 25134101 PubMed
  6. Saguil A, Kane S, Mercado M, Lauters R. Herpes zoster and postherpetic neuralgia: Prevention and management. Am Fam Physician 2017 Nov 15;96(10):656-663. PMID: 29431387 PubMed
  7. Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44 Suppl 1: S1.
  8. Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007; 82: 1341. PubMed
  9. Albrecht MA. Epidemiology, clinical manifestations, and diagnosis of herpes zoster. UpToDate. Sist oppdatert 11.02.2025. Sist lest: 19.06.2025. www.uptodate.com
  10. Dai S, Huang X, Chen Y, et al. Bilateral asymmetrical herpes-zoster with Ramsay hunt syndrome in an immunocompetent adult. Virol J. 2020;17(1):123. Published 2020 Aug 15. PMID: 32799908 PubMed
  11. Albrecht MA. Treatment of herpes zoster in the immunocompetent host. UpToDate. Sist oppdatert: 09.05.2025. Sist lest: 19.06.2025. www.uptodate.com
  12. Werner RN, Nikkels AF, Marinović B, et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. J Eur Acad Dermatol Venereol. 2017 Jan;31(1):20-29. PMID: 27579792. PubMed
  13. Gnann JW, Whitley RJ. Herpes zoster. N Engl J Med 2002; 347: 340-6. PubMed
  14. Colin J, Prisant O, Cochener B, Lescale O, Rolland B, Hoang-Xuan T. Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus. Br J Ophthalmol 2000; 107: 1507-11. PMID: 10919899 PubMed
  15. John AR, Canaday DH. Herpes Zoster in the Older Adult. Infect Dis Clin North Am. 2017;31(4):811-826. PMID: 29079160 PubMed
  16. Chen N, Li Q, Yang J, Zhou M, Zhou D, He L. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2014;2014(2):CD006866. Published 2014 Feb 6. PMID:24500927 pubmed.ncbi.nlm.nih.gov
  17. Pasternak B, Hviid A. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA. 2010;304(8):859-866. PMID: 20736469 PubMed
  18. RELIS - KUPP Brosjyre - Riktige bruk av PPI. Publisert mai 2024. Siden lest: 22.06.2025 relis.no
  19. RELIS. Kuppbrosjyre 2015. Riktigere bruk av NSAIDs. Terapiråd til helsepersonell. Publisert 21.09.2016. Siden lest 30.03.2023. relis.no
  20. Jiang X, Li Y, Chen N, Zhou M, He L. Corticosteroids for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2023;12(12):CD005582. Published 2023 Dec 5. PMID: 38050854 PubMed
  21. Schmader K. Herpes Zoster. Ann Intern Med. 2018 Aug 7;169(3):ITC19-ITC31. doi: 10.7326/AITC201808070. Erratum in: Ann Intern Med. 2018 Oct 2;169(7):516. PMID: 30083718 PubMed
  22. FHI - Vaksinasjonshåndboka. Sist oppdatert 20.12.2024. Sist lest: 19.06.2025. www.fhi.no
  23. de Oliveira Gomes J, Gagliardi AM, Andriolo BN et.al. Vaccines for preventing herpes zoster in older adults. Cochrane Database Syst Rev. 2023 Oct 2;PMID: 37781954 PubMed
  24. Eyting M, Xie M, Michalik F, Heß S, Chung S, Geldsetzer P. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025;641(8062):438-446. PMID: 40175543 PubMed
  25. Pomirchy M, Bommer C, Pradella F, Michalik F, Peters R, Geldsetzer P. Herpes Zoster Vaccination and Dementia Occurrence. JAMA. 2025;333(23):2083-2092. PMID: 40267506 PubMed
  26. Lee S, Lee K, Oh J, et al. Live zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study. Eur Heart J. Published online May 5, 2025. PMID: 40324473 PubMed
  27. Jiang X, Li Y, Chen N, et al. Corticosteroids for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2023; 12: CD005582. pmid:38050854 PubMed
  28. Breuer J, Pacoud M, Gauthier A, Brown MM. Herps zoster as a risk factor for stroke and TIA. Neurology 2014. PMID: 24384645 PubMed
  29. Wang YP, Liu CJ, Hu YW, et al. Risk of cancer among patients with herpes zoster infection: a population-based study. CMAJ 2012 Oct 16; 184(15): E804-9. PMID: 22988158. PubMed
  30. Gebo KA, Kalyani R, Moore RD, Polydefkis MJ. The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era. J Acquir Immune Defic Syndr 2005; 40: 169. PubMed
Annonse
Annonse